Navigation Links
Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
Date:12/6/2007

a regulatory review of eprodisate (KIACTA(TM)). The Marketing Authorization Application is being reviewed under the Agency's centralized procedure. This means that an authorization from this Agency would apply to all 27 European Union member states, as well as to Norway and Iceland. An oral hearing occurred with the EMEA in November 2007 to discuss outstanding issues raised with respect to the eprodisate (KIACTA(TM)) application and a decision from the EMEA is expected by year-end, or shortly thereafter.

The Company also filed for marketing approval for eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis in Switzerland. A decision is expected in 2008.

Eprodisate (KIACTA(TM)) has received orphan drug status in the United States, the European Union and in Switzerland.
Neurochem Inc. sponsored the EFAAT study.

About Amyloid A (AA) Amyloidosis

A progressive and fatal condition, AA amyloidosis occurs in a proportion of patients with chronic inflammatory disorders, chronic infections and inherited diseases such as familial Mediterranean fever. The kidney is the organ most frequently affected and progression to dialysis/end-stage renal disease is the most common clinical manifestation in this disease. Currently, there is no approved therapy to treat AA amyloidosis and about half of all patients diagnosed with the disease die within five years of diagnosis.

About Neurochem Inc.

Neurochem Inc. is a global health company focused on the research, development and commercialization of products to provide innovative health solutions to patients suffering from serious diseases.

To Contact Neurochem Inc.

For additional information on Neurochem and its drug development programs, please call the North American toll-free number 1 877 680-4500 or visit the Web Site at http://www.neurochem.com.

Certain statements contained in this news release, other than
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Neurochem reports results for third quarter of fiscal 2007
2. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)..., BETHESDA, Md., Jan. 8 /PRNewswire-Asia/ -- C...DX" or "the Company"), a leading independent Ameri...ervices in the People,s Republic,of China, today ...S Greater,China Conference, to be held in Shangha...Greater China Conference will be held at the Pudon...
(Date:1/8/2009)..., ROCKVILLE, Md., Jan. 8 /PRNewswire-USNewswire/ -...tives, advice and guidance on drugs, biological pr...lthcare Research and Quality,s Centers for Educati...ly sponsored network of more than a dozen leading ...er Health Advisory Information Network ( CHAIN ) ...
(Date:1/8/2009)..., FRAZER, Pa., Jan. 8 C...hat Frank Baldino, Jr., Ph.D., Chairman and CEO wi...ce, to be held on January 13, 2009 in San Francisc....m. Eastern Time). The presentation will be webcas...mpany,s website. , , The webcast will be archi...
(Date:1/8/2009)..., Company,s Email Encryption business continues to...PRNewswire-FirstCall/ -- Zix Corporation (ZixCorp(...ces for email encryption and e-prescribing, today ...officer, Rick Spurr. , , "We ended the year on ...e booked the highest orders for the year in the fo...
Breaking Medicine News(10 mins):Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4
...an influence a persons diet. Those who dont get en... and, instead, opt to eat fast food. It is the lac...d food that may cause health problems for these pe...riedman, PhD, of the City University of New York, ...
...esearch abstract that will be presented Monday at ...ng infants and toddlers born prematurely occurs e...gher rates than among full-term infants. The stud...Downs, PhD, of West Virginia University, consisted...
...first -of -its-kind case, a teenager died due to a...muscles. Arielle Newman, 17, from Staten Island,...gly high amount of methyl salicylate, the active i...discovered in her body. Various companies such a...
...d practitioners have always believed, and now they...therapy can help offer relief to people with chron...itioners and academics will be carrying out a 12-w... scientifically determine whether or not it can he...
Other Medicine News:Health News:American Sports Star Teenager Dies Due To Overdose Of Muscle Cream 2Health News:Yoga to Be Scientifically Tested as Therapy for Chronic Low Back Pain 2
(Date:1/8/2009)... Jan. 8 If you are taking prescrip... not alone. Half of the people taking,prescriptio...s are,varied -- they forget, are busy with other ...Noncompliance has been called the Achilles heel of...rett Koop commented, "Drugs don,t,work in people ...
(Date:1/7/2009)...n., Jan. 7 Scientists h...high likelihood of relapse in children with acute ...hers caution that further research is needed to de... IKAROS, lead to leukemia relapse, the findings ...tic tests to assess the risk of treatment failure....
(Date:1/7/2009).... 7 Tiantan Puhua Hospital Stem Ce...worldwide leader in using stem cells to effectivel...x new globally experienced additions to its medica... hospital,s treatment capabilities for growing num...enior doctors include the distinguished Dr. Jiang ...
(Date:1/6/2009)...., Jan. 6 In recent controlled stu... of Memphis , scientists found that the patented i...irst and only proven ingredient to increase levels...ing blood nitrate/nitrate (NOx) in human subjects....bles an increase in blood flow to the skeletal mus...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2Donald W Wyatt Detention Facility Scores 3 Year Accreditation and Among Highest Rated in the United States 15967 1Donald W Wyatt Detention Facility Scores 3 Year Accreditation and Among Highest Rated in the United States 15967 2Donald W Wyatt Detention Facility Scores 3 Year Accreditation and Among Highest Rated in the United States 15967 3International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital 28TM 29 Initiative 4401 1International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital 28TM 29 Initiative 4401 2International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital 28TM 29 Initiative 4401 3Data From Ortho Biotech Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 1687 1Data From Ortho Biotech Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 1687 2Data From Ortho Biotech Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 1687 3Data From Ortho Biotech Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 1687 4Data From Ortho Biotech Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 1687 5Data From Ortho Biotech Sponsored Studies to be Presented at National Kidney Foundation 2008 Spring Clinical Meetings 1687 6Study finds economic burden of health insurance increasing for small employers 15962 1Study finds economic burden of health insurance increasing for small employers 15962 2
...IRE)--May 23, 2007 - Cytogen,Corporation (NASDAQ: ...alidating the utility of its ProChart(TM) database...aining oxidoreductase,(WWOX), an important tumor s...rostate, lung, pancreatic, esophageal, and gastric...in the online,edition (25 April 2007) of the Journ...
...RE)--May 23, 2007 - Northfield,Laboratories, Inc. ...al Phase III trauma trial with PolyHeme(R), its hu...l substitute. The,trial was designed to seek an in...ing red blood cell loss when transfusion is,requir...use,interchangeably with blood. This indication ad...
Other Medicine Technology:Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 2Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 3Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 4Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 2Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 3Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 4Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 5Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 6Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 7Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 8
The new TRC-NW200 Non-Mydriatic Retinal Camera combines Topcons years of experience in retinal imaging with the latest advances in digital and electronic technology.
...532 laser is indicated for the treatment of vascul...ia, rosacea, spider angiomas, cherry angiomas, por...gra and keratoses. Patented solid-state technolog...andpieces maximizes versatility, compact size allo...
EndoProbe handpieces, used for endophotocoagulation indications, provide the ophthamologist with uncompromised laser treatment of intravitreal pathologies. EndoProbe handpieces are compatible with I
...Imaging Consultant, PDA Edition is designed for al... diagnostic imaging studies. It provides speedy ac...tion that will help to determine whether imaging e...which studies will generate the most information. ...
Medicine Products: